Practice Management
President-elect Trump has announced his intended appointment of Janette Nesheiwat, MD, to be the next surgeon general, according to NPR. She is currently a medical director for CityMD and has contributed to Fox News. With a specialization in emergency and family medicine, she is known for supporting vaccine efforts with an emphasis on the balance of risk and benefit. CityMD merged with Summit Health and was ultimately acquired by VillageMD in early 2023 for $8.9 …
Read More
The American Academy of Pediatrics (AAP) has issued its first clinical practice guideline on prescribing opioids for outpatient acute pain management in children, published in Pediatrics. The guideline recommends using immediate-release opioids at the lowest dose for age- and weight-appropriateness, with an initial supply of no more than 5 days unless the pain is due to trauma or surgery requiring longer treatment. Codeine and tramadol should not be prescribed to children under 12, adolescents with …
Read More
In a study of 320,141 children published in JAMA Network, researchers found those treated with amoxicillin-clavulanate had a slightly higher risk of treatment failure (defined as lack of effectiveness or intolerability) compared with amoxicillin. And for those treated with amoxicillin-clavulanate, there was also a higher risk of gastrointestinal symptoms and yeast infections. Accessing treatment in urgent care was more common among patients who received amoxicillin-clavulanate (9.6%) than those who received amoxicillin (5.9%), and urgent care …
Read More
In the week ending November 9, 2024, 30%-40% of adults had received 2 of the most recommended vaccines, according to the latest update from the Centers for Disease Control and Prevention (CDC). An estimated 34.7% of adults reported having received a seasonal influenza vaccine, and 39.7% of adults age 75 and older have received a respiratory syncytial virus (RSV) vaccine. Likewise, 31.6% of adults aged 60–74 years at increased risk have received an RSV vaccine. …
Read More
Attempts to disrupt or supplant primary care haven’t gone as planned for a number of ambitious start-ups. After raising more than $600 million and reaching a valuation of $1 billion, Forward has abruptly canceled already-scheduled patient visits, disabled its app, and began shutting down its clinic locations last week. The Forward model was based on cash payment for direct primary care backed by tech-enabled care automation. Reportedly, the company had technical issues with its automated …
Read More
The Centers for Disease Control and Prevention (CDC) reports that respiratory virus activity remains low nationally, while also confirming the first pediatric flu death of the 2024-2025 season, recorded in the middle of October. Overall, 201 laboratory-confirmed influenza-associated hospitalizations were reported between October 1 and November 2, 2024. Weekly trend lines show an increase of 2.4% in terms of outpatient visits to healthcare providers for respiratory illnesses for the week ending November 2. Separately, the …
Read More
Caffeinated drinks seem to have become a lifestyle for American teens and tweens. A recent study from Epic Research showed that emergency department (ED) visits connected to consuming excessive amounts of caffeine nearly doubled among some age groups from 2017 to 2023. For kids ages 15 to 18, the rate increased from 7.4 per 100,000 visits in 2017 to 13.6 per 100,000 visits in 2023. But for kids ages 11 to 14, visits related to …
Read More
Breaking a 10-month stalemate, WellNow Urgent Care and Excellus BlueCross BlueShield (BCBS) have at last executed a new contract agreement, putting WellNow back in-network as of November 15, 2024, according to an email from WellNow. Excellus insurance plans covered about 300,000 WellNow visits in New York last year. At least 40 centers are located in Central New York where hospital closures in recent years have provided WellNow opportunities to fill gaps in access. “At WellNow …
Read More
The Food and Drug Administration (FDA) is looking to remove oral phenylephrine from its list of approved over-the-counter ingredients. After a committee review, the oral decongestant was unanimously determined to be ineffective, according to FDA. However, removal from store shelves would occur no earlier than 2026, and the agency emphasizes that its proposed ban is based on effectiveness concerns, not on safety concerns. Over-the-counter oral phenylephrine has been on the market for 30 years. Chime …
Read More
In a sobering cross-sectional study, researchers found that healthcare workers in emergency departments (EDs) experience workplace violence at a rate of once every 3.7 shifts. Even worse, in the large urban ED study site, 25% of the incidents involved physical violence, as published in JAMA Network Open. The odds of experiencing violence increased for those in a nursing role and workers of a younger age. Those who experienced violence reported they were moderately or severely …
Read More